AC Immune SA (ACIU)
2.25
+0.06
(+2.74%)
USD |
NASDAQ |
Jun 09, 16:00
2.25
0.00 (0.00%)
After-Hours: 20:00
AC Immune Research and Development Expense (Quarterly) : 14.99M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| BeOne Medicines Ltd. | 521.31M |
| CRISPR Therapeutics AG | 66.37M |
| Idorsia Ltd. | 33.91M |
| ADC Therapeutics SA | 19.88M |
| MoonLake Immunotherapeutics | 53.67M |